Ligand-independent CXCR7 Activation of MAPK Signaling leads to Prostate Cancer Enzalutamide Resistance

ABSTRACT: Ligand-independent CXCR7 Activation of MAPK Signaling leads to Prostate Cancer Enzalutamide Resistance

PROVIDER: PRJNA414193 | ENA |

REPOSITORIES: ENA